Semaglutide
medicationA GLP-1 medication that reduces appetite, approved for weight management and type 2 diabetes.
Guide
Peptides are short chains of amino acids; under FDA rules, a chain of more than 40 is a protein. Some peptides are FDA-approved prescription drugs, such as semaglutide and tesamorelin. “Peptide therapy” usually means clinic-offered peptides, many with little human evidence. Peptides are legal when approved or lawfully compounded on a prescription; research peptides are not for human use.

A peptide is a short chain of amino acids, the same building blocks that make up proteins. FDA regulations define a protein as an amino acid chain of more than 40 amino acids, so shorter chains are generally called peptides. 21 CFR 600.3

A protein is, under FDA regulations, any alpha amino acid polymer with a specific, defined sequence that is greater than 40 amino acids in size. 21 CFR 600.3
Insulin, first made as a therapy in 1921, is described as the first therapeutic peptide. Therapeutic peptides
Since March 23, 2020, insulin products have been regulated in the US as biological products rather than as drugs. FDA (Feb 2020)
Several well-known medicines are peptides. On DiscoverMedica, semaglutide (Wegovy, Ozempic), tirzepatide (Zepbound, Mounjaro), liraglutide (Saxenda, Victoza) and tesamorelin (Egrifta) are FDA-approved peptide drugs with official prescribing information. Worldwide, more than 80 peptide drugs have been approved. Therapeutic peptides

An approved peptide has passed FDA review for a specific use. A compounded peptide is prepared by a licensed pharmacy for an individual prescription, using an ingredient FDA allows for compounding, and is not FDA-approved. A research peptide is sold as a laboratory chemical, is not for human use, and has no lawful route to you. FDA

Products sold as research chemicals carry labels such as “not for human or veterinary use,” and FDA treats them as unapproved drugs when they are marketed for people. FDA warning letter
| Item | FDA-approved | Compounded | Research only |
|---|---|---|---|
| FDA reviewed for safety and effectiveness | Yes | No | No |
| Needs a prescription | Yes | Yes | Sold without one |
| Made by | A drug manufacturer | A licensed pharmacy or outsourcing facility | An unregulated seller |
| Examples on DiscoverMedica | Semaglutide, tirzepatide, tesamorelin | Sermorelin | BPC-157, TB-500, retatrutide |
No. Topical peptides such as GHK-Cu, a copper peptide, are sold legally as cosmetic ingredients. Injectable GHK-Cu is a separate, unapproved use; non-injectable GHK-Cu is in FDA’s 503A Category 1, with an advisory committee review planned. FDA
“Peptide therapy” is a marketing term, not a defined treatment. Clinics use it for injected peptides such as BPC-157, TB-500, CJC-1295 with ipamorelin, tesamorelin and GHK-Cu. A 2026 review for sports medicine physicians found the evidence for these uses is largely preclinical, and said their indications, frequency and duration of use remain unknown. Injectable peptide therapy
The same review notes that tesamorelin is approved only for HIV-associated lipodystrophy, with no supporting orthopaedic evidence, and that BPC-157 findings are largely unvalidated in human trials. Injectable peptide therapy
Where a clinic offers a peptide, the lawful versions are an FDA-approved drug used on or off label, or a compounded product made by a licensed pharmacy from an ingredient FDA allows for compounding. Compounded drugs are not FDA-approved. FDA
It depends on the peptide and the route. An FDA-approved peptide drug is legal with a prescription. A compounded peptide is lawful only when a licensed pharmacy makes it for an individual prescription from an eligible ingredient. Cosmetic peptides in skin care need no FDA approval. Peptides sold “for research use only” are not lawful for human use. FDA
FDA treats a product marketed for people as a drug whatever its label says, and has sent warning letters to sellers of peptides labeled “for research use only.” FDA warning letter
Sport has its own rules: the World Anti-Doping Agency prohibits many peptides at all times, BPC-157 among them, even where no criminal law applies. USADA
For the details on a single peptide, see the BPC-157 legal status guide and the guide to what “research use only” means, both linked below.
| Kind of product | Lawful for a person to use? | Example on DiscoverMedica |
|---|---|---|
| FDA-approved peptide drug | Yes, on a prescription | Semaglutide, tirzepatide, tesamorelin |
| Compounded peptide from an eligible ingredient | Yes, on an individual prescription from a licensed pharmacy | Sermorelin |
| Topical cosmetic peptide | Yes, as a cosmetic; no FDA approval is required | GHK-Cu in skin care |
| Peptide on FDA’s Category 2 safety list | Pharmacies should not compound it under FDA’s interim policy | Kisspeptin-10 |
| Research-only peptide | No lawful route for human use | BPC-157, TB-500, retatrutide |
Check its regulatory status, not the marketing. An FDA-approved peptide has prescribing information on DailyMed and is dispensed by a pharmacy on a prescription. A research peptide has neither. Every compound page on DiscoverMedica states its status first. Wegovy label
Adds Semaglutide, Tirzepatide, Liraglutide, Tesamorelin, Sermorelin, GHK-Cu to My Journal, with the questions to ask a clinician. It stays in this browser, and nothing on it is a commitment.
Licensed providers that list each one on DiscoverMedica, by name. The full list is on each compound’s page.
Prices as listed by the provider when we checked; they change.
Yes. Semaglutide is a lab-made version of GLP-1, a peptide hormone, and it is an FDA-approved prescription drug sold as Wegovy, Ozempic and Rybelsus.
Research peptides are not approved for human use. When a seller markets them for people, FDA treats them as unapproved drugs and has sent warning letters. The “research use only” label does not make them lawful or safe to use, and DiscoverMedica links to no seller.
It depends entirely on which peptide. Approved peptide drugs have known benefits and risks listed on their labels. Research peptides have little or no human safety data, and FDA has flagged risks such as immune reactions for several of them.
Some are. FDA-approved peptide drugs are legal on a prescription, compounded peptides are lawful when a licensed pharmacy makes them from an eligible ingredient for an individual prescription, and cosmetic peptides are legal in skin care. Peptides sold for “research use only” have no lawful route for human use.
“Peptide therapy” is not a single treatment, so it has no FDA approval of its own. A few peptides clinics use are approved drugs for specific conditions; compounded peptides are not FDA-approved; and research peptides such as BPC-157 are not approved for any human use.
For any peptide drug you inject or swallow, yes: approved and compounded peptide drugs both require a prescription from a licensed clinician. Topical cosmetic peptides, such as copper peptides in skin care, are sold without one.
Last reviewed October 7, 2026. Every source above was checked on or before that date. Educational information only, not medical advice; it does not replace a conversation with a licensed clinician. DiscoverMedica does not employ clinicians.
A GLP-1 medication that reduces appetite, approved for weight management and type 2 diabetes.
A weekly GIP and GLP-1 medication approved for weight management, sleep apnea and type 2 diabetes.
An older, daily GLP-1 injection for weight management and diabetes, now available as a generic.
An FDA-approved growth-hormone-releasing peptide for belly fat in people with HIV.
A peptide that prompts your pituitary to release growth hormone. Available compounded.
A copper peptide common in skin-care serums. Injectable versions are not approved.
A lab-made peptide popular for injury recovery. Mostly animal data, and not an approved drug.
A synthetic fragment of thymosin beta-4 marketed for recovery. Animal data only; not approved.